During the past decade, Premier Research conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 35 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 15 clinical trials were completed. i.e. 115.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Premier Research" #1 sponsor was "Pfizer" with 16 trials, followed by "Eli Lilly and Company" with 9 trials sponsored, "Iroko Pharmaceuticals, LLC" with 8 trials sponsored, "AstraZeneca" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Premier Research" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Premier Research" are "Type 2 Diabetes" (6 trials), "Dental Pain" (5 trials), "Obesity" (4 trials), "Osteoarthritis" (4 trials) and "Diabetes Mellitus, Type 2" (3 trials). Many other conditions were trialed in "Premier Research" in a lesser frequency.

Most popular intervention types in "Premier Research" are "Drug" (54 trials), "Other" (8 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Dapagliflozin" (3 trials), "Dulaglutide" (3 trials), "Tirzepatide" (3 trials) and "BFKB8488A" (2 trials). Other intervention names were less common.

The vast majority of trials in "Premier Research" are 57 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Premier Research". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Premier Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Premier Research, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".